Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Dermatologic 1

Conditions

Keratosis, Actinic 2Skin Neoplasms 1Precancerous Conditions 1Carcinoma, Basal Cell 1

Interventions

Sulindac 4Biopsy 4Carboplatin 3Vaginal Smears 2Cyclophosphamide 2Colposcopy 2Aspirin 2tanespimycin 1sargramostim 1pirfenidone 1fludarabine phosphate 1alethine 1Radiotherapy 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Papanicolaou Test 1Mycophenolic Acid 1Microarray Analysis 1Lovastatin 1Interleukin-12 Subunit p35 1Interferon-alpha 1Inositol 1Ifosfamide 1Genetic Linkage 1Gene Expression Profiling 1Fluorophotometry 1FANG vaccine 1Erlotinib Hydrochloride 1Endoscopy, Digestive System 1Endoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Precancerous Conditions × Deoxyribonuclease (Pyrimidine Dimer) × Clear all
NCT00002811 2013-11-06

T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum

National Cancer Institute (NCI)

Phase 3 Unknown
30 enrolled
DermatologicOther neoplasm

Precancerous Conditions, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡